PapersFlow Research Brief
Nanoplatforms for cancer theranostics
Research Guide
What is Nanoplatforms for cancer theranostics?
Nanoplatforms for cancer theranostics are nanotechnology-based systems that integrate diagnostic imaging and therapeutic functions for simultaneous cancer detection and treatment.
The field encompasses 64,299 works focused on nanoparticles, photothermal therapy, reactive oxygen species, fluorescence imaging, and photodynamic therapy. These platforms enable tumor targeting, near-infrared imaging, and theranostic agents combining diagnosis and therapy. Research also addresses immunotherapy and biomimetic nanoparticles for improved cancer treatment outcomes.
Topic Hierarchy
Research Sub-Topics
Gold Nanorod Photothermal Therapy
Researchers design gold nanorods with tuned NIR plasmon resonance for tumor ablation, optimizing PEGylation, targeting ligands, and laser parameters. Studies evaluate efficacy in xenograft models and safety profiles.
Mesoporous Silica Nanoparticles Drug Delivery
This sub-topic explores MSNs for controlled release of chemotherapeutics, stimuli-responsive gating, and surface functionalization for tumor homing. Biodistribution and pharmacokinetics are assessed in vivo.
Photodynamic Therapy with Nanoparticles
Scientists develop nanoparticle-photosensitizer conjugates for improved ROS generation, oxygen delivery, and deep-tissue PDT. Research includes upconversion nanoparticles and hypoxia alleviation strategies.
Near-Infrared Fluorescence Imaging Nanoparticles
Work focuses on NIR dye-doped or quantum dot nanoparticles for high-resolution tumor imaging, multiplexing, and ratiometric sensing of biomarkers. Translational studies validate clinical potential.
Biomimetic Nanoparticles for Tumor Targeting
Researchers engineer cell membrane-coated or virus-mimicking nanoparticles to evade immune clearance and exploit EPR/homing. Combinatorial therapy with immunotherapy is a key focus.
Why It Matters
Nanoplatforms enable targeted cancer interventions, as shown by nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance, where L. R. Hirsch et al. (2003) demonstrated tumor ablation in mice with optical transmission through tissue. Gold nanorods provide cancer cell imaging and photothermal therapy in the near-infrared region, with Xiaohua Huang et al. (2006) reporting strong absorption for molecular imaging and therapy. Doxil®, the first FDA-approved nano-drug, delivered pegylated liposomal doxorubicin, with Yechezkel Barenholz (2012) detailing its clinical lessons including reduced cardiotoxicity in over 500,000 patients treated since approval.
Reading Guide
Where to Start
'Photodynamic therapy for cancer' by D.E. Dolmans, Dai Fukumura, and Rakesh K. Jain (2003) provides a foundational overview of PDT mechanisms central to many nanoplatforms.
Key Papers Explained
'Photodynamic therapy for cancer' (Dolmans et al., 2003; 6575 citations) establishes PDT basics, extended by 'Cancer Cell Imaging and Photothermal Therapy in the Near-Infrared Region by Using Gold Nanorods' (Huang et al., 2006; 5331 citations) introducing nanoparticle-enhanced imaging and therapy. 'Calculated Absorption and Scattering Properties of Gold Nanoparticles of Different Size, Shape, and Composition' (Jain et al., 2006; 4450 citations) builds on this with optical property predictions, while 'Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance' (Hirsch et al., 2003; 3873 citations) demonstrates in vivo application. 'Cancer nanomedicine: progress, challenges and opportunities' (Shi et al., 2016; 5417 citations) synthesizes these advances with clinical perspectives.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Current work emphasizes tumor targeting with reactive oxygen species and biomimetic nanoparticles, though no recent preprints are available. Frontiers include optimizing near-infrared theranostics and immunotherapy integration based on established nanoparticle designs from top papers.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Photodynamic therapy for cancer | 2003 | Nature reviews. Cancer | 6.6K | ✕ |
| 2 | Cancer nanomedicine: progress, challenges and opportunities | 2016 | Nature reviews. Cancer | 5.4K | ✓ |
| 3 | Cancer Cell Imaging and Photothermal Therapy in the Near-Infra... | 2006 | Journal of the America... | 5.3K | ✕ |
| 4 | Photodynamic therapy of cancer: An update | 2011 | CA A Cancer Journal fo... | 5.0K | ✓ |
| 5 | In vivo cancer targeting and imaging with semiconductor quantu... | 2004 | Nature Biotechnology | 4.7K | ✕ |
| 6 | Photodynamic Therapy | 1998 | JNCI Journal of the Na... | 4.6K | ✓ |
| 7 | Calculated Absorption and Scattering Properties of Gold Nanopa... | 2006 | The Journal of Physica... | 4.5K | ✕ |
| 8 | Doxil® — The first FDA-approved nano-drug: Lessons learned | 2012 | Journal of Controlled ... | 4.4K | ✕ |
| 9 | Nanoshell-mediated near-infrared thermal therapy of tumors und... | 2003 | Proceedings of the Nat... | 3.9K | ✓ |
| 10 | A clearer vision for in vivo imaging | 2001 | Nature Biotechnology | 3.7K | ✕ |
Frequently Asked Questions
What is photodynamic therapy in cancer nanoplatforms?
Photodynamic therapy involves administration of a tumor-localizing photosensitizing agent followed by light activation at a specific wavelength, resulting in photochemical processes that kill malignant cells. D.E. Dolmans, Dai Fukumura, and Rakesh K. Jain (2003) described its mechanism in 'Photodynamic therapy for cancer'. Patrizia Agostinis et al. (2011) updated its clinical use as a minimally invasive procedure selective for cancer cells.
How do gold nanoparticles function in cancer theranostics?
Gold nanoparticles, such as nanorods and nanoshells, exhibit enhanced absorption and scattering due to strong surface electric fields, enabling near-infrared imaging and photothermal therapy. Xiaohua Huang et al. (2006) showed gold nanorods for cancer cell imaging and therapy in 'Cancer Cell Imaging and Photothermal Therapy in the Near-Infrared Region by Using Gold Nanorods'. Prashant K. Jain et al. (2006) calculated their optical properties for biological imaging in 'Calculated Absorption and Scattering Properties of Gold Nanoparticles of Different Size, Shape, and Composition: Applications in Biological Imaging and Biomedicine'.
What are key applications of nanoplatforms in cancer imaging?
Semiconductor quantum dots enable in vivo cancer targeting and imaging with high sensitivity. Xiaohu Gao et al. (2004) demonstrated this in 'In vivo cancer targeting and imaging with semiconductor quantum dots'. Gold nanoshells support magnetic resonance-guided thermal therapy, as L. R. Hirsch et al. (2003) applied in 'Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance'.
What challenges exist in cancer nanomedicine?
Challenges include overcoming biological barriers and scaling clinical translation. Jinjun Shi et al. (2016) outlined progress and hurdles in 'Cancer nanomedicine: progress, challenges and opportunities'. Yechezkel Barenholz (2012) provided lessons from Doxil® in 'Doxil® — The first FDA-approved nano-drug: Lessons learned', noting formulation stability and toxicity management.
How do theranostic agents combine imaging and therapy?
Theranostic agents integrate diagnostic imaging with therapeutic delivery using nanoparticles tuned for specific optical properties. Naomi J. Halas and Jennifer L. West's group (Hirsch et al., 2003) used nanoshells for near-infrared absorption in therapy under MR guidance. Mostafa A. El-Sayed's team (Huang et al., 2006) applied gold nanorods for simultaneous imaging and photothermal effects.
Open Research Questions
- ? How can nanoplatforms improve penetration of photosensitizers in solid tumors for photodynamic therapy?
- ? What nanoparticle designs optimize near-infrared absorption for deep-tissue photothermal therapy?
- ? How do biomimetic nanoparticles enhance immunotherapy targeting in heterogeneous tumors?
- ? Which surface modifications best balance tumor accumulation and clearance for theranostic agents?
- ? What metrics predict clinical translation success for nanoparticle-based cancer therapies?
Recent Trends
The field has accumulated 64,299 works, with sustained focus on nanoparticles for photothermal and photodynamic therapy as evidenced by high citations of papers like 'Photodynamic therapy for cancer' (Dolmans et al., 2003; 6575 citations) and 'Cancer nanomedicine: progress, challenges and opportunities' (Shi et al., 2016; 5417 citations).
No recent preprints or news coverage in the last 12 months indicates steady maturation without abrupt shifts.
Research Nanoplatforms for cancer theranostics with AI
PapersFlow provides specialized AI tools for Engineering researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
Code & Data Discovery
Find datasets, code repositories, and computational tools
AI Academic Writing
Write research papers with AI assistance and LaTeX support
See how researchers in Engineering use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Nanoplatforms for cancer theranostics with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Engineering researchers